International society for rheumatic therapy guest society symposium: Recent therapeutic experiences with new generation drugs for inflammatory diseases

被引:0
|
作者
B. White
机构
[1] University of Maryland,Research Service (151), Baltimore VA Medical Center
关键词
D O I
10.1007/BF02684003
中图分类号
学科分类号
摘要
引用
收藏
页码:73 / 75
页数:2
相关论文
共 15 条
  • [1] Updating the Italian Society for Rheumatology recommendations for biologic therapy in adult patients with inflammatory rheumatic diseases
    Montecucco, C.
    Caporali, R.
    Matucci-Cerinic, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (03) : S3 - S6
  • [2] Recommendations of the German Society for Rheumatology on the perioperative Approach under Therapy with DMARDs and Biologicals in inflammatory rheumatic Diseases
    Krueger, K.
    Albrecht, K.
    Rehart, S.
    Scholz, R.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2014, 73 (01): : 77 - 84
  • [4] Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021
    Ding, Wen-Xing
    Wang, Hua
    Zhang, Yuxia
    LIVER RESEARCH, 2022, 6 (01) : 50 - 57
  • [6] Proceedings of the ISCT scientific signature series symposium, "Advances in cell and gene therapies for lung diseases and critical illnesses" International Society for Cell & Gene Therapy, Burlington VT, US, July 16, 2021
    Ting, Anthony E.
    Baker, Elizabeth K.
    Champagne, Josee
    Desai, Tushar J.
    dos Santos, Claudia C.
    Heijink, Irene H.
    Itescu, Silviu
    Le Blanc, Katarina
    Matthay, Michael A.
    McAuley, Daniel F.
    McIntyre, Lauralynn
    Mei, Shirley H. J.
    Parekkadan, Biju
    Rocco, Patricia R. M.
    Sheridan, John
    Thebaud, Bernard
    Weiss, Daniel J.
    CYTOTHERAPY, 2022, 24 (08) : 774 - 788
  • [8] Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
    Cyrus Cooper
    Thomas Bardin
    Maria-Luisa Brandi
    Patrice Cacoub
    John Caminis
    Roberto Civitelli
    Maurizio Cutolo
    Willard Dere
    Jean-Pierre Devogelaer
    Adolfo Diez-Perez
    Thomas A. Einhorn
    Patrick Emonts
    Olivier Ethgen
    John A. Kanis
    Jean-Marc Kaufman
    Tore K. Kvien
    Willem F. Lems
    Eugene McCloskey
    Pierre Miossec
    Susanne Reiter
    Johann Ringe
    René Rizzoli
    Kenneth Saag
    Jean-Yves Reginster
    Aging Clinical and Experimental Research, 2016, 28 : 1 - 16
  • [9] Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
    Cooper, Cyrus
    Bardin, Thomas
    Brandi, Maria-Luisa
    Cacoub, Patrice
    Caminis, John
    Civitelli, Roberto
    Cutolo, Maurizio
    Dere, Willard
    Devogelaer, Jean-Pierre
    Diez-Perez, Adolfo
    Einhorn, Thomas A.
    Emonts, Patrick
    Ethgen, Olivier
    Kanis, John A.
    Kaufman, Jean-Marc
    Kvien, Tore K.
    Lems, Willem F.
    McCloskey, Eugene
    Miossec, Pierre
    Reiter, Susanne
    Ringe, Johann
    Rizzoli, Rene
    Saag, Kenneth
    Reginster, Jean-Yves
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 28 (01) : 1 - 16
  • [10] CLINICAL CHALLENGES IN HYPERTENSION - THERAPEUTIC APPLICATIONS OF NEW VASODILATING BETA-BLOCKERS - SYMPOSIUM PROCEEDINGS HELD IN ASSOCIATION WITH THE 13TH SCIENTIFIC MEETING OF THE INTERNATIONAL-SOCIETY-OF-HYPERTENSION MONTREAL, CANADA JUNE, 1990 - INTRODUCTION
    BIRKENHAGER, WH
    HAMET, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : R1 - R1